# Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

> **NCT02162485** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 129 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salmeterol/fluticasone Easyhaler
- **DRUG:** Salmeterol/fluticasone Easyhaler with charcoal
- **DRUG:** Seretide Diskus
- **DRUG:** Seretide Diskus with charcoal

## Key facts

- **NCT ID:** NCT02162485
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2015-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02162485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02162485, "Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02162485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*